Drug Profile


Alternative Names: Indiplon modified-release; Indiplon-IR; Indiplon-IR capsules; Indiplon-MR; Indiplon-MR tablets; NBI 34060; NBI 34060 modified-release; NBI 34060-IR; NBI 34060-MR

Latest Information Update: 25 Jun 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Neurocrine Biosciences
  • Class Hypnosedatives; Sleep disorder therapies; Small molecules; Thiophenes
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Insomnia

Most Recent Events

  • 13 Dec 2007 Discontinued - Phase-III for Insomnia in Canada (PO)
  • 13 Dec 2007 Discontinued - Phase-III for Insomnia in Europe (PO)
  • 13 Dec 2007 Discontinued - Phase-III for Insomnia in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top